HENRY MANNING: Open Payments
NPI 1164416335 · DUBLIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,258 in 56 payments from 14 companies in 2025. Trend: 2023 $868 · 2024 $1,077 · 2025 $1,258
Food & beverage: $1,258
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $259 |
| Regeneron Healthcare Solutions, Inc. | 8 | $224 |
| GENZYME CORPORATION | 5 | $178 |
| E.R. Squibb & Sons, L.L.C. | 5 | $100 |
| Janssen Biotech, Inc. | 4 | $92 |
| Lilly USA, LLC | 3 | $75 |
| Incyte Corporation | 4 | $70 |
| PFIZER INC. | 3 | $55 |
| Organon LLC | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
Products named: DUPIXENT, SKYRIZI, Sotyktu, RINVOQ, TREMFYA, OPZELURA, TALTZ, COSENTYX.
Industry payments across GA — which companies pay providers there.
